Skip to main content
Fig. 5 | BMC Anesthesiology

Fig. 5

From: Efficacy of esketamine for the treatment of postpartum depression and pain control following cesarean section: a randomized, double-blind, controlled clinical trial

Fig. 5

Expression levels of the inflammation inducing factors of PPD were compared between the control group and the esketamine group on the 3rd post-operative day. A expression levels of IL-6 and BDNF between the two groups on postoperative day 3. B CRP expression levels between the two groups on day 3 after surgery. PPD, postpartum depression; IL-6, interleukin-6; BDNF, brain-derived neurotrophic factor; CRP, C-reactive protein

Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us